Rhode Island Lawmakers Introduce Magic Mushroom Bill
However, the Rhode Island bill's enactment would be contingent with federal approval.
March 3, 2023
MDMA Treatment for PTSD Shows Promise in Clinical Trial
Trial found “no serious adverse events were observed in either the MDMA group or the control group.”
January 12, 2023
FDA Mulls Over CBD Regulation
The FDA has concerns over certain foods and supplements that are mixed with the cannabis compound.
December 30, 2022
Google Updates Policy To Allow Hemp, CBD Products with Certification
Google has updated its policy to allow hemp and CBD advertising in California, Colorado, and Puerto Rico.
December 29, 2022
FDA Takes First Step in Making NARCAN Available Over the Counter
NARCAN, a true miracle drug that can reverse opiate overdoses at the drop of a hat and save the user’s life, may soon become much more widely accessible to addicts.
November 17, 2022
Need for Speed: FDA Issues Notice on Adderall Shortages
In case rampant inflation, the sudden death of Hagrid, and the ever-increasing threat of nuclear war weren’t enough—apparently we’re running low on drugs.
October 20, 2022
Idaho Halts Sale of CBD Pet Supplements
Idaho will enforce the ban in November.
September 20, 2022
Canadian Senator Admits He Takes Psilocybin for Depression
Seventy-four-year-old Senator Larry Campbell’s wife secretly microdosed him by spiking his coffee with psilocybin.
May 23, 2022
The Retail Fallacy: Stop Buying off THC Percentage
For the first edition of WEIRDOS, our VP of Content kicks off the conversation with a rant on why THC percentages are bullshit, and why you should ignore them. Go buy with your nose!
May 20, 2022
New Study Confirms Safety of CBD
A new study confirms the safety of CBD, renewing calls from the hemp industry for the FDA to regulate cannabidiol products.
May 18, 2022